| Acute abdomen - management in pregnancy |
| Advanced Maternal Age (AMA) and Outcomes |
| Anaemia and Haemoglobinopathies in Pregnancy |
| Antenatal Visits Provided in the Community Guideline |
| Antepartum Haemorrhage |
| Blood pressure measurement on a pregnant woman guideline |
| Blood Products Refusal in Pregnancy |
| Cardiotocography (CTG) - Antenatal |
| Cholestasis of Pregnancy - Diagnosis and Management |
| Corticosteroids - for women at risk of preterm birth or with a fetus at risk of respiratory distress - antenatal |
| Early labour assessment in the woman's home |
| Estimating due date (EDD) |
| Fetal Growth Assessment in Pregnancy Guideline |
| Fetal Movements - Identification and Management of Reduced Patterns |
| Group B Streptococcus (GBS) Screening and Prophylaxis |
| Hepatitis B Positive Mothers and their Babies |
| Hepatitis C Positive Mothers and their Babies |
| Herpes simplex in pregnancy and birth |
| High Order Multiple Pregnancy - Antenatal Care |
| Hot Packs Application Guideline |
| Human Immunodeficiency Virus (HIV) in Pregnancy, Birth and Postpartum period |
| Hyperemesis Gravidarim and Nausea and Vomiting in Pregnancy - Management |
| Monoamniotic Twins - Management |
| Next Birth after Caesarean Section (NBAC) |
| Parvovirus B19 Screening and Management in Pregnancy |
| Placenta Praevia |
| Postdates - Management of Pregnancy beyond 41 weeks gestation |
| Preterm Premature Rupture of Membranes (PPROM) - Assessment and Management Guideline |
| Progesterone prevention of Preterm Labour |
| Referral to Department of Maternal Fetal Medicine - Fetal Indications |
| Sexual Transmitted Infections (STI) Blood Born Viruses (BBV) Antenatal Screening and Treatment |
| Thrombocytopenia in Pregnancy |
| Thyroid Disease in Pregnancy |
| Twin pregnancy – Antenatal Care |
| Vaginal swab - high |
| Women who choose to refuse recommended monitoring and treatment in Maternity Services in SESLHD -SESLHDPR/482 |
